secwatch.observer — SEC 8-K summary ====================================== Issuer: AVANOS MEDICAL, INC. (AVNS) CIK: 0001606498 Form: 8-K Filed at: 2024-07-31T23:59:59+00:00 Accession: 0001606498-24-000074 Event type: earnings Sentiment: neutral Materiality: 0.30 Item codes: 2.02, 9.01 LLM model: deepseek-v4-flash:cloud@v2 Avanos Medical reports Q2 2024 results; filing lacks detailed financials ------------------------------------------------------------------------ - Results announced for three and six months ended June 30, 2024. - No specific revenue, EPS, or segment figures available in provided text. - Guidance or outlook not mentioned in the filing excerpt. Source: EDGAR index: https://www.sec.gov/Archives/edgar/data/1606498/000160649824000074/0001606498-24-000074-index.htm Primary doc: https://www.sec.gov/Archives/edgar/data/1606498/000160649824000074/avns-20240731.htm HTML page: https://secwatch.observer/filing/0001606498-24-000074 License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer